Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_1
1
25%
Ph phase_3
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Active, not recruiting1
Not yet recruiting1
Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

active_not_recruiting125%
not_yet_recruiting125%
completed125%
withdrawn125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_1

Pomalidomide as an Immune-enhancing Agent for the Control of HIV

NCT06660498
not_yet_recruitingnot_applicable

Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women

NCT07041385
completednot_applicable

Aspirin Role for Preventing Clinical Risks Related to High Risk Pregnancy

NCT07087067
withdrawnphase_3

The Effect Of Aspirin On Survival in Lung Cancer

NCT01058902

Clinical Trials (4)

Showing 4 of 4 trials
NCT06660498Phase 1

Pomalidomide as an Immune-enhancing Agent for the Control of HIV

Active Not Recruiting
NCT07041385Not Applicable

Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women

Not Yet Recruiting
NCT07087067Not Applicable

Aspirin Role for Preventing Clinical Risks Related to High Risk Pregnancy

Completed
NCT01058902Phase 3

The Effect Of Aspirin On Survival in Lung Cancer

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4